Evidence map›Paper›PMID 29983461›Full record

ArticleColombia medica (Cali, Colombia)2018

Reliable information for cancer control in Cali, Colombia.

Luis Eduardo Bravo, Luz Stella García, Paola Collazos, Edwin Carrascal, Oscar Ramírez, Tito Collazos, Armando Cortés, Marcela Nuñez, Erquinovaldo Millan

Open access · diamondAbstract read
In one paragraph

Article in Colombia medica (Cali, Colombia), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Colorectal cancer survival in Manizales, Colombia, 2008-2017: a population-based study.Revista brasileira de epidemiologia = Brazilian journal of epidemiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Quality of life in women treated with chemotherapy for breast cancer in Cali, ColombiaBiomedica : revista del Instituto Nacional de Salud · 2020
    Observational
  11. Article
  12. The Cancer Observatory of Cali, a priority.Colombia medica (Cali, Colombia) · 2018
    Article
  13. Article
  14. Epidemiology of cancer in Colombia.Colombia medica (Cali, Colombia) · 2018
    Article
  15. Article
  16. Article
  17. Observational
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Luis Eduardo BravoRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Luz Stella GarcíaRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Paola CollazosRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Edwin CarrascalRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Oscar RamírezRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Tito CollazosRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Armando CortésDepartamento de Patología, Facultad de Salud, Universidad del Valle, Cali, Colombia.
Marcela NuñezRegistro Poblacional de Cáncer de Cali. Cali, Colombia.
Erquinovaldo MillanSecretaria de Salud Pública Municipal de Cali, Cali, Colombia.
Universidad del Valle · COSecretaría de Salud de Bogotá · CO

Funding

Project 3 - Molecular Signatures of Gastric Carcinogenesis in the Host Response to H. pyloriP01CA028842 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI WILSON, KEITH T. · 1985 to 2019
$15.8M
NCI NIH HHS P01 CA028842
6 · The paper itself

Abstract

backgroundThe Cali Population Cancer Registry (RPCC) has been in continuous operation since 1962 with the objective of producing valid statistics on the incidence of cancer, its patterns, trends and survival rates.

methodsDuring the period 2008-2012, 23,046 new cases were registered and during 2011-2015 there were 12,761 cancer deaths. The trend of the rates was described with the APC average annual change rate and with the Joinpoint analysis. We analyzed the individual data of 38,671 adults (15-99 years) diagnosed with cancer between 1995-2009, and we calculated the standardized net survival by age for the 14 most common cancer body sites, using the Pohar-Perme method.

resultsProstate and breast cancer were the first cause of cancer morbidity. The incidence rates in these were susceptible to early detection, tumors stabilized after decades of growth, while an increase in the incidence of colon cancer and papillary thyroid carcinoma was observed. The incidence rates of cervical and stomach cancer and conditions related to infectious agents decreased, although the number of absolute cases increased, due to the growth and aging of the population. Gastric cancer was responsible for the highest number of cancer related deaths. The types of cancer related to tobacco consumption (lung, oral cavity, esophagus, pancreas, urinary bladder) showed low numbers and a tendency to decrease. During the period 2000-2004, the 5-year net survival improved for cancers of the breast, cervix, prostate, melanoma and thyroid, although in the period 2005-2009 a stagnation was observed. In stomach, liver and lung cancer, the 5-year net survival was less than 15%. The 5-year overall survival in children was 51.0% (95% CI: 47.5, 54.3) and in adolescents 44.6% (95% CI: 36.0, 52.8). COMMENT: RPCC has been an advisor to the Colombian government in the evaluation of CPRs in the country and its data has contributed significantly to different aspects of cancer control in Colombia.

Indexed as

AdolescentAdultAgedAged, 80 and overAge DistributionChildChild, PreschoolColombiaFemaleHumansIncidenceInfantMaleMiddle AgedMorbidityMortalityCaliCancer registryColombiaincidencemethodsmortalitysurvival

Identifiers

PMID29983461
PMCPMC6018818
OpenAlexW2800228876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.